Clinical Trial Update: GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men [Phase 4]

View source ↗

Summary

Phase 4 trial update reports that GLP-1 receptor agonism stimulates browning of subcutaneous white adipose tissue in men with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: Xiang Guang-da | Conditions: Obesity | Phase 4 | Status: COMPLETED